rs1205 — CRP +1846C>T

3' UTR variant that modulates baseline C-reactive protein levels and inflammatory status

See your personal result for CRP

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

C-Reactive Protein Levels — A Genetic Thermostat for Inflammation

C-reactive protein (CRP) is one of the body's oldest inflammatory markers, a pentameric protein synthesized by the liver in response to interleukin-6 signaling. During acute infection or injury, CRP levels can surge 1,000-fold within 24 hours11 CRP levels can surge 1,000-fold within 24 hours
CRP is a sensitive acute-phase reactant, making it a valuable clinical marker. But baseline CRP levels — the levels you carry when you're healthy — are substantially influenced by genetics, with 30-40% of variation explained by genetic factors22 30-40% of variation explained by genetic factors
Heritability studies estimate genetic contribution at 30-40%. The rs1205 polymorphism in the 3' untranslated region (3' UTR) of the CRP gene is among the strongest genetic determinants of these baseline levels.

The Mechanism

The rs1205 variant sits at position +1846 in the 3' UTR of the CRP gene on chromosome 1q23.2 . This region doesn't change the amino acid sequence of the CRP protein, but it regulates how much protein gets made. The 3' UTR contains binding sites for microRNAs and RNA-binding proteins that control mRNA stability and translation efficiency.

The rs1205 polymorphism likely acts as a molecular switch, differentially influenced by distinct molecular environments .

The Evidence

The rs1205-CRP relationship is one of the most consistently replicated associations in inflammation genetics.

In 327 postmenopausal Brazilian women, the CC genotype showed 1.53 times higher prevalence of low-grade chronic inflammation (hs-CRP ≥3 mg/L) compared to T allele carriers . This chronic low-grade inflammation is a key mechanism linking obesity, metabolic syndrome, and cardiovascular disease.

In early rheumatoid arthritis patients, the TT genotype was associated with a 50% reduction in baseline CRP levels (from 16.7 to 8.4 mg/L, P = 0.005) , though this effect disappeared after one year of treatment, suggesting the variant primarily affects constitutional rather than disease-driven CRP production.

The CRP-lowering T allele is overrepresented in systemic lupus erythematosus, where it interacts with type I interferon signaling to produce inappropriately low CRP responses despite active inflammation .

Practical Implications

Your rs1205 genotype influences your baseline inflammatory set point — the CRP level your body maintains in the absence of acute illness. This matters because elevated hs-CRP independently predicts all-cause mortality (RR 1.75), cardiovascular mortality (RR 2.03), and cancer mortality (RR 1.25) .

For CC homozygotes — particularly those with elevated waist circumference, obesity, or metabolic syndrome — the combination of genetic predisposition and environmental factors can create persistent low-grade inflammation. This inflammatory state accelerates atherosclerosis, insulin resistance, and risk of type 2 diabetes.

The good news: CRP levels are modifiable. Weight loss reduces CRP by approximately 0.13 mg/L per kilogram lost. Regular aerobic exercise lowers CRP by 0.34-0.59 mg/L. Mediterranean dietary patterns can reduce CRP by ~1.0 mg/L. Smoking cessation in people with established cardiovascular disease reduces CRP by 0.40 mg/L, with greater benefits the longer one remains smoke-free.

Interactions

The rs1205 variant commonly exists in haplotypes with other CRP SNPs, particularly rs1130864, rs3093059, and rs2794521.

The CGCA haplotype (rs1205-C, rs1130864-G, rs2794521-C, rs3093059-A) is associated with decreased type 2 diabetes risk (OR 0.83) .

Genotype Interpretations

What each possible genotype means for this variant.

CT Intermediate CRP Intermediate

Moderate genetic influence on baseline inflammation

You carry one copy of the C allele and one copy of the T allele at rs1205. About 42% of people of European ancestry share this genotype. Your baseline CRP levels fall between those of CC and TT homozygotes, typically lower than CC carriers in healthy populations. The T allele provides partial protection against inflammation-driven conditions, but doesn't confer the same degree of baseline CRP reduction seen in TT homozygotes.

TT Low Baseline CRP Decreased

Genetically lower baseline inflammatory markers with context-dependent effects

Your genotype's effects depend critically on health status and disease context. In healthy individuals and those with inflammatory conditions like rheumatoid arthritis, TT carriers show substantially reduced CRP production. The T allele is also overrepresented in systemic lupus erythematosus, where it interacts with type I interferon to produce inappropriately blunted CRP responses despite active disease. This suggests your genotype may affect not just baseline levels but also the capacity to increase CRP appropriately during acute inflammation.

CC High Baseline CRP High

Genetically higher baseline inflammatory markers

You carry two copies of the C allele at rs1205, which is associated with higher baseline C-reactive protein levels. About 45% of people of European ancestry share this genotype. In healthy populations, this genotype typically results in hs-CRP levels higher than TT carriers, though absolute levels remain within the normal range in the absence of obesity or metabolic dysfunction. This represents your constitutional inflammatory set point — not active disease, but your body's baseline readiness to mount inflammatory responses.